NASDAQ:WBA - Walgreens Boots Alliance Stock Price, Price Target & More

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance announced a quarterly dividend on Friday, June 29th. Stockholders of record on Monday, August 20th will be paid a dividend of $0.44 per share on Wednesday, September 12th. This represents a $1.76 annualized dividend and a dividend yield of 2.71%. The ex-dividend date of this dividend is Friday, August 17th. This is an increase from Walgreens Boots Alliance's previous quarterly dividend of $0.40. View Walgreens Boots Alliance's Dividend History.

Walgreens Boots Alliance announced that its board has approved a share buyback plan on Thursday, October 26th 2017, which allows the company to buyback $1,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company's board believes its shares are undervalued.

Walgreens Boots Alliance Inc (NASDAQ:WBA) announced its earnings results on Thursday, June, 28th. The pharmacy operator reported $1.53 EPS for the quarter, topping the consensus estimate of $1.47 by $0.06. The pharmacy operator had revenue of $34.33 billion for the quarter, compared to analyst estimates of $34.15 billion. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The company's quarterly revenue was up 14.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.33 earnings per share. View Walgreens Boots Alliance's Earnings History.

Walgreens Boots Alliance issued an update on its FY18 earnings guidance on Thursday, June, 28th. The company provided EPS guidance of $5.90-6.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.95.

18 brokers have issued twelve-month target prices for Walgreens Boots Alliance's shares. Their forecasts range from $60.00 to $96.00. On average, they anticipate Walgreens Boots Alliance's stock price to reach $77.0588 in the next twelve months. This suggests a possible upside of 18.6% from the stock's current price. View Analyst Ratings for Walgreens Boots Alliance.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating, 11 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Walgreens Boots Alliance saw a increase in short interest in the month of June. As of June 15th, there was short interest totalling 17,165,556 shares, an increase of 15.9% from the May 31st total of 14,810,457 shares. Based on an average daily volume of 5,380,135 shares, the days-to-cover ratio is currently 3.2 days. Currently, 2.0% of the shares of the company are short sold. View Walgreens Boots Alliance's Current Options Chain.

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Media headlines about WBA stock have been trending somewhat positive this week, according to Accern. Accern identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Walgreens Boots Alliance earned a coverage optimism score of 0.07 on Accern's scale. They also gave news headlines about the pharmacy operator an impact score of 47.13 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Walgreens Boots Alliance's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.17%), Hexavest Inc. (0.14%), Assenagon Asset Management S.A. (0.10%), Retirement Systems of Alabama (0.08%), Gateway Investment Advisers LLC (0.07%) and Boston Advisors LLC (0.05%). Company insiders that own Walgreens Boots Alliance stock include Janice M Babiak, John Anthony Lederer, Kathleen Wilson-Thompson, Ornella Barra, Stefano Pessina and William C Foote. View Institutional Ownership Trends for Walgreens Boots Alliance.

WBA stock was sold by a variety of institutional investors in the last quarter, including Hartford Investment Management Co., Benjamin F. Edwards & Company Inc., Welch & Forbes LLC, Guidant Wealth Advisors, Grassi Investment Management, Municipal Employees Retirement System of Michigan, Gofen & Glossberg LLC IL and Jacobs & Co. CA. View Insider Buying and Selling for Walgreens Boots Alliance.

WBA stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Boston Advisors LLC, Retirement Systems of Alabama, Bank of Montreal Can, RNC Capital Management LLC, Cornerstone Wealth Management LLC, DnB Asset Management AS and Manning & Napier Group LLC. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Janice M Babiak, John Anthony Lederer, Ornella Barra and Stefano Pessina. View Insider Buying and Selling for Walgreens Boots Alliance.

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of WBA stock can currently be purchased for approximately $64.98.

Walgreens Boots Alliance has a market capitalization of $64.49 billion and generates $118.21 billion in revenue each year. The pharmacy operator earns $4.08 billion in net income (profit) each year or $5.10 on an earnings per share basis. Walgreens Boots Alliance employs 345,000 workers across the globe.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]